Within the Electronic Prescribing System (EPS), repeat dispensing prescriptions are issued individually by the prescribing system and signed and sent individually to Spine as required for the patient. There is a dependency on the prescribing system to retain the information after a migration as it needs to continue generating prescription issues for the authorised period.
– Any outstanding repeat dispensing issues held on the Spine for a patient will therefore need to be cancelled and reissued after go-live. Avoid future dating EPS prescriptions as this could lead to errors in the original system during the cutover. This is also a good time to advise the partner pharmacies in your area so they could also prepare for this.
– A report can be run within the practice to identify patients likely to be affected, as this will allow any new or remaining issues to be lined up with the cutover dates. For example, a patient who has a six-monthly set of issues could have their last issue of six due in the period covering cutover, so they will not need a re-issue of these until after go-live.
Keep a record of all prescription requests made/issued during the ‘cutover’ period. Ideally batch all the repeat prescription requests together by date order. If any requests are taken by phone/over the counter/any other method, you will need to make a note of those and add them to the batched information
To reduce the amount of effort to re-enter prescription data, some practices choose to:
– Issue two prescriptions (either post-dated or by amending the quantity) from the month before the ‘cutover’ begins until a week after go-live. Note: Do not post-date prescriptions sent via EPS.
– For EPS repeat prescriptions, practices can revert back to issuing FP10 forms from the month before the ‘cutover’ begins until a week after go-live. Changing the option from EPS to FP10 forms needs to happen on an individual patient basis. This can be done at the point of ordering all medications.
With either of these options it is important that patients and pharmacies are informed of this change at the earliest opportunity to avoid any confusion